Fingerprint
Dive into the research topics of 'Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group
Aerang Kim, Brigitte C. Widemann, Mark Krailo, Nalini Jayaprakash, Elizabeth Fox, Brenda Weigel, Susan M. Blaney
Research output: Contribution to journal › Article › peer-review
41
Scopus
citations